|
US9433684B2
(en)
|
2008-08-19 |
2016-09-06 |
Nektar Therapeutics |
Conjugates of small-interfering nucleic acids
|
|
TWI510246B
(zh)
|
2010-04-30 |
2015-12-01 |
Molecular Partners Ag |
抑制ｖｅｇｆ－ａ受體交互作用的經修飾結合性蛋白質
|
|
US9284361B2
(en)
|
2010-11-26 |
2016-03-15 |
Molecular Partners Ag |
Designed repeat proteins binding to serum albumin
|
|
SG191955A1
(en)
|
2011-02-15 |
2013-08-30 |
Immunogen Inc |
Cytotoxic benzodiazepine derivatives
|
|
JP6209159B2
(ja)
|
2011-06-21 |
2017-10-04 |
イミュノジェン・インコーポレーテッド |
ペプチドリンカーを有する新規メイタンシノイド誘導体およびその結合体
|
|
WO2014031566A1
(en)
|
2012-08-22 |
2014-02-27 |
Immunogen, Inc. |
Cytotoxic benzodiazepine derivatives
|
|
EP2738180A1
(en)
|
2012-11-30 |
2014-06-04 |
Molecular Partners AG |
Binding proteins comprising at least two binding domains against HER2.
|
|
JP6423804B2
(ja)
|
2013-02-28 |
2018-11-14 |
イミュノジェン・インコーポレーテッド |
細胞結合剤及び細胞毒性剤を含む複合体
|
|
WO2014134483A2
(en)
|
2013-02-28 |
2014-09-04 |
Immunogen, Inc. |
Conjugates comprising cell-binding agents and cytotoxic agents
|
|
WO2014194030A2
(en)
|
2013-05-31 |
2014-12-04 |
Immunogen, Inc. |
Conjugates comprising cell-binding agents and cytotoxic agents
|
|
WO2014191574A1
(en)
|
2013-05-31 |
2014-12-04 |
Molecular Partners Ag |
Designed ankyrin repeat proteins binding to hepatocyte growth factor
|
|
CN105873952A
(zh)
|
2013-10-31 |
2016-08-17 |
弗莱德哈钦森癌症研究中心 |
经修饰的造血干细胞/祖细胞和非t效应细胞及其用途
|
|
PL3083671T3
(pl)
|
2013-12-20 |
2021-03-22 |
Fred Hutchinson Cancer Center |
Znakowane chimeryczne cząsteczki efektorowe i ich receptory
|
|
US10665324B2
(en)
|
2014-07-07 |
2020-05-26 |
Yeda Research And Development Co. Ltd. |
Method of computational protein design
|
|
MX2017002758A
(es)
|
2014-09-03 |
2017-10-20 |
Immunogen Inc |
Derivados de benzodiazepina citotoxicos.
|
|
JP2017527562A
(ja)
|
2014-09-03 |
2017-09-21 |
イミュノジェン・インコーポレーテッド |
細胞毒性ベンゾジアゼピン誘導体
|
|
HK1246317A1
(zh)
|
2015-03-05 |
2018-09-07 |
Fred Hutchinson Cancer Center |
免疫调节融合蛋白及其用途
|
|
SG11201707606RA
(en)
|
2015-04-02 |
2017-10-30 |
Molecular Partners Ag |
Designed ankyrin repeat domains with binding specificity for serum albumin
|
|
EP3288569A4
(en)
|
2015-04-29 |
2018-12-19 |
Fred Hutchinson Cancer Research Center |
Modified hematopoietic stem/progenitor and non-t effector cells, and uses thereof
|
|
WO2016176652A2
(en)
|
2015-04-29 |
2016-11-03 |
Fred Hutchinson Cancer Research Center |
Modified stem cells and uses thereof
|
|
WO2017106728A2
(en)
*
|
2015-12-16 |
2017-06-22 |
University Of Washington |
Repeat protein architectures
|
|
CR20180503A
(es)
|
2016-04-14 |
2018-12-21 |
Hutchinson Fred Cancer Res |
Composiciones y métodos para programar células terapéuticas utilizando nanoportadores de ácidos nucleicos dirigidos
|
|
KR102270315B1
(ko)
|
2016-09-22 |
2021-06-29 |
몰리큘라 파트너스 아게 |
재조합 결합 단백질 및 그의 용도
|
|
CA3052779A1
(en)
|
2017-02-17 |
2018-08-23 |
Fred Hutchinson Cancer Research Center |
Combination therapies for treatment of bcma-related cancers and autoimmune disorders
|
|
SG10202109376YA
(en)
|
2017-02-28 |
2021-10-28 |
Immunogen Inc |
Maytansinoid derivatives with self-immolative peptide linkers and conjugates thereof
|
|
WO2018165046A1
(en)
|
2017-03-07 |
2018-09-13 |
Igc Bio, Inc. |
A computational pipeline for antibody modeling and design
|
|
JP2020511136A
(ja)
|
2017-03-17 |
2020-04-16 |
フレッド ハッチンソン キャンサー リサーチ センター |
免疫調節性融合タンパク質およびその使用
|
|
WO2018195243A1
(en)
|
2017-04-20 |
2018-10-25 |
Immunogen, Inc. |
Cytotoxic benzodiazepine derivatives and conjugates thereof
|
|
WO2019133652A1
(en)
|
2017-12-28 |
2019-07-04 |
Immunogen, Inc. |
Benzodiazepine derivatives
|
|
US12398402B2
(en)
|
2018-09-12 |
2025-08-26 |
Fred Hutchinson Cancer Center |
Reducing CD33 expression to selectively protect therapeutic cells
|
|
CA3133802A1
(en)
|
2019-03-21 |
2020-09-24 |
Immunogen, Inc. |
Methods of preparing cell-binding agent-drug conjugates
|
|
CN113661172A
(zh)
|
2019-03-29 |
2021-11-16 |
伊缪诺金公司 |
用于抑制异常细胞生长或治疗增生性疾病的细胞毒性双苯并二氮杂䓬衍生物及其与细胞结合剂的缀合物
|
|
CN119119176A
(zh)
|
2019-04-26 |
2024-12-13 |
伊缪诺金公司 |
喜树碱衍生物
|
|
AU2020286715A1
(en)
|
2019-06-04 |
2021-12-23 |
Molecular Partners Ag |
Recombinant 4-1 BB binding proteins and their use
|
|
CN114269366A
(zh)
|
2019-06-04 |
2022-04-01 |
分子伴侣公司 |
重组fap结合蛋白及其用途
|
|
CA3138805A1
(en)
|
2019-06-04 |
2020-12-10 |
Johannes Schilling |
Designed ankyrin repeat domain with improved stability
|
|
SG11202111943UA
(en)
|
2019-07-02 |
2021-11-29 |
Hutchinson Fred Cancer Res |
Recombinant ad35 vectors and related gene therapy improvements
|
|
US20230041822A1
(en)
|
2019-12-11 |
2023-02-09 |
Molecular Partners Ag |
Recombinant peptide-mhc complex binding proteins and their generation and use
|
|
CA3161326A1
(en)
|
2019-12-11 |
2021-06-17 |
Molecular Partners Ag |
Designed ankyrin repeat domains with altered surface residues
|
|
US20230142283A1
(en)
*
|
2020-03-05 |
2023-05-11 |
University Of Washington |
Rigid helical junctions for modular repeat protein sculpting and methods of use
|
|
TW202208404A
(zh)
|
2020-05-06 |
2022-03-01 |
瑞士商分子組合公司 |
新穎錨蛋白重複結合蛋白質及其用途
|
|
BR112022023049A2
(pt)
|
2020-05-14 |
2022-12-20 |
Molecular Partners Ag |
Proteínas multiespecíficas
|
|
JP2023528207A
(ja)
|
2020-05-14 |
2023-07-04 |
モレキュラー パートナーズ アクチェンゲゼルシャフト |
組換えｃｄ４０結合タンパク質及びそれらの使用
|
|
US20240108746A1
(en)
|
2020-12-16 |
2024-04-04 |
Molecular Partners Ag |
Novel slow-release prodrugs
|
|
WO2022129428A1
(en)
|
2020-12-16 |
2022-06-23 |
Molecular Partners Ag |
Recombinant cd3 binding proteins and their use
|
|
CA3211248A1
(en)
|
2021-03-09 |
2022-09-15 |
Nina RESCHKE |
Novel darpin based cd33 engagers
|
|
EP4305063A1
(en)
|
2021-03-09 |
2024-01-17 |
Molecular Partners AG |
Protease cleavable prodrugs
|
|
WO2022190016A1
(en)
|
2021-03-09 |
2022-09-15 |
Molecular Partners Ag |
Novel darpin based multi-specific t-cell engagers
|
|
CA3211368A1
(en)
|
2021-03-09 |
2022-09-15 |
Molecular Partners Ag |
Novel darpin based cd123 engagers
|
|
WO2023110983A1
(en)
|
2021-12-14 |
2023-06-22 |
Molecular Partners Ag |
Designed repeat domains with dual binding specificity and their use
|
|
US20250368704A1
(en)
*
|
2022-01-07 |
2025-12-04 |
Universität Zürich |
Stabilizing n-cap sequences for armadillo repeat proteins
|
|
WO2023215725A1
(en)
|
2022-05-02 |
2023-11-09 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|
|
CA3262553A1
(en)
|
2022-08-01 |
2024-02-08 |
Molecular Partners Ag |
REHEARSAL AREAS DESIGNED WITH MODIFIED CHARGES AND THEIR USE
|
|
WO2024179981A1
(en)
|
2023-02-27 |
2024-09-06 |
Molecular Partners Ag |
Darpins for use in reducing renal accumulation of drugs
|
|
WO2024251695A1
(en)
|
2023-06-06 |
2024-12-12 |
Molecular Partners Ag |
Recombinant cd47 binding proteins and their use
|
|
WO2024251628A1
(en)
|
2023-06-06 |
2024-12-12 |
Molecular Partners Ag |
Recombinant cd16a binding proteins and their use
|
|
WO2024251742A1
(en)
|
2023-06-06 |
2024-12-12 |
Molecular Partners Ag |
Recombinant cd2 binding proteins and their use
|
|
WO2025068607A1
(en)
*
|
2023-09-29 |
2025-04-03 |
Universität Zürich |
Modular armadillo repeat proteins
|
|
WO2025101820A1
(en)
|
2023-11-08 |
2025-05-15 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|
|
WO2025146491A1
(en)
|
2024-01-05 |
2025-07-10 |
Molecular Partners Ag |
Designed repeat domains with dual binding specificity for cd117 and cd47-binding agent
|
|
WO2025146487A1
(en)
|
2024-01-05 |
2025-07-10 |
Molecular Partners Ag |
Multispecific binding proteins
|
|
WO2025146490A1
(en)
|
2024-01-05 |
2025-07-10 |
Molecular Partners Ag |
Recombinant cd117 binding proteins and their use
|
|
WO2025163082A1
(en)
|
2024-01-31 |
2025-08-07 |
Molecular Partners Ag |
Dll3-specific binding constructs and their use in radiotherapy
|
|
WO2025163144A1
(en)
|
2024-01-31 |
2025-08-07 |
Molecular Partners Ag |
Recombinant mesothelin binding proteins and their use
|
|
WO2025181039A1
(en)
|
2024-03-01 |
2025-09-04 |
Molecular Partners Ag |
Therapeutic combinations comprising a multi-specific t cell engager
|
|
WO2025245169A1
(en)
|
2024-05-21 |
2025-11-27 |
Fred Hutchinson Cancer Center |
Immunotherapy cells equipped with a collagen-targeting payload
|